{"id":"https://openalex.org/W1769466758","doi":"https://doi.org/10.1200/jco.1994.12.1.141","title":"Escalating dose of mitoxantrone with high-dose cyclophosphamide, carmustine, and etoposide in patients with refractory lymphoma undergoing autologous bone marrow transplantation.","display_name":"Escalating dose of mitoxantrone with high-dose cyclophosphamide, carmustine, and etoposide in patients with refractory lymphoma undergoing autologous bone marrow transplantation.","alternate_titles":[],"publication_year":1994,"publication_date":"1994-01-01","ids":{"openalex":"https://openalex.org/W1769466758","doi":"https://doi.org/10.1200/jco.1994.12.1.141","mag":"1769466758","pmid":"https://pubmed.ncbi.nlm.nih.gov/8270970"},"language":"en","primary_location":{"id":"doi:10.1200/jco.1994.12.1.141","doi":"https://doi.org/10.1200/jco.1994.12.1.141","is_oa":false,"landing_page_url":"https://doi.org/10.1200/jco.1994.12.1.141","pdf_url":null,"source":{"id":"https://openalex.org/S15137598","display_name":"Journal of Clinical Oncology","issn_l":"0732-183X","issn":["0732-183X","1527-7755"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Oncology","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W1769466758"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5025996929","display_name":"Michel Attal","orcid":"https://orcid.org/0000-0002-0136-9665","observed_orcids":["https://orcid.org/0000-0002-0136-9665"]},"institutions":[{"id":"https://openalex.org/I4210138343","display_name":"H\u00f4pital Purpan","ror":"https://ror.org/03vcx3f97","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I3019448017","https://openalex.org/I4210138343"]}],"countries":["FR"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"M Attal","raw_affiliation_strings":["Department of Hematology, Purpan Hospital, Toulouse, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Hematology, Purpan Hospital, Toulouse, France","institution_ids":["https://openalex.org/I4210138343"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5041701219","display_name":"Pierre Canal","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"P Canal","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5012476442","display_name":"Daniel Schlaifer","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"D Schlaifer","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5002862341","display_name":"\u00c9tienne Chatelut","orcid":"https://orcid.org/0000-0002-7740-9096","observed_orcids":["https://orcid.org/0000-0002-7740-9096"]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"E Chatelut","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5047989197","display_name":"A Dezeuze","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"A Dezeuze","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5004066423","display_name":"Fran\u00e7oise Huguet","orcid":"https://orcid.org/0000-0002-9576-8578","observed_orcids":["https://orcid.org/0000-0002-9576-8578"]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"F Huguet","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5088027893","display_name":"Catherine Payen","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"C Payen","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5083981481","display_name":"J Pris","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"J Pris","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5103453300","display_name":"Guy Laurent","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"G Laurent","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":1.9693,"has_fulltext":false,"cited_by_count":35,"citation_normalized_percentile":{"value":0.88120805,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":86,"max":94},"biblio":{"volume":"12","issue":"1","first_page":"141","last_page":"148"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10185","display_name":"Lymphoma Diagnosis and Treatment","score":0.9740999937057495,"subfield":{"id":"https://openalex.org/subfields/2734","display_name":"Pathology and Forensic Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10185","display_name":"Lymphoma Diagnosis and Treatment","score":0.9740999937057495,"subfield":{"id":"https://openalex.org/subfields/2734","display_name":"Pathology and Forensic Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10345","display_name":"Hematopoietic Stem Cell Transplantation","score":0.015200000256299973,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12172","display_name":"Neutropenia and Cancer Infections","score":0.0012000000569969416,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/mitoxantrone","display_name":"mitoxantrone","score":1.0},{"id":"https://openalex.org/keywords/high-dose-cyclophosphamide","display_name":"high-dose cyclophosphamide","score":0.7850000262260437},{"id":"https://openalex.org/keywords/carmustine","display_name":"BCNU","score":0.9580000042915344},{"id":"https://openalex.org/keywords/etoposide","display_name":"etoposide","score":0.996999979019165},{"id":"https://openalex.org/keywords/refractory-lymphoma","display_name":"refractory lymphoma","score":0.9300000071525574},{"id":"https://openalex.org/keywords/autologous-bone-marrow-transplantation","display_name":"autologous bone marrow transplantation","score":0.9919999837875366},{"id":"https://openalex.org/keywords/maximum-tolerated-dose","display_name":"maximum tolerated dose","score":0.8610000014305115},{"id":"https://openalex.org/keywords/dose-finding-studies","display_name":"dose-finding studies","score":0.6660000085830688},{"id":"https://openalex.org/keywords/pharmacokinetics","display_name":"pharmacokinetics","score":0.8309999704360962},{"id":"https://openalex.org/keywords/neutropenia","display_name":"neutropenia","score":0.9240000247955322},{"id":"https://openalex.org/keywords/complete-response","display_name":"complete response","score":0.7139999866485596},{"id":"https://openalex.org/keywords/hematological-toxicity","display_name":"hematologic toxicity","score":0.5220000147819519}],"concepts":[{"id":"https://openalex.org/C2780147359","wikidata":"https://www.wikidata.org/wiki/Q415869","display_name":"Carmustine","level":4,"score":0.9025185108184814},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.897804856300354},{"id":"https://openalex.org/C2778119113","wikidata":"https://www.wikidata.org/wiki/Q418817","display_name":"Etoposide","level":3,"score":0.7423732280731201},{"id":"https://openalex.org/C2780923524","wikidata":"https://www.wikidata.org/wiki/Q239426","display_name":"Mitoxantrone","level":3,"score":0.7106159329414368},{"id":"https://openalex.org/C2776755627","wikidata":"https://www.wikidata.org/wiki/Q408524","display_name":"Cyclophosphamide","level":3,"score":0.6081587076187134},{"id":"https://openalex.org/C29730261","wikidata":"https://www.wikidata.org/wiki/Q274160","display_name":"Toxicity","level":2,"score":0.5674757957458496},{"id":"https://openalex.org/C112705442","wikidata":"https://www.wikidata.org/wiki/Q323936","display_name":"Pharmacokinetics","level":2,"score":0.5182744860649109},{"id":"https://openalex.org/C2777063308","wikidata":"https://www.wikidata.org/wiki/Q1435822","display_name":"Neutropenia","level":3,"score":0.5080552101135254},{"id":"https://openalex.org/C142424586","wikidata":"https://www.wikidata.org/wiki/Q7307572","display_name":"Refractory (planetary science)","level":2,"score":0.42850080132484436},{"id":"https://openalex.org/C2911091166","wikidata":"https://www.wikidata.org/wiki/Q106419912","display_name":"Transplantation","level":2,"score":0.4274076819419861},{"id":"https://openalex.org/C90924648","wikidata":"https://www.wikidata.org/wiki/Q120569","display_name":"Gastroenterology","level":1,"score":0.41132399439811707},{"id":"https://openalex.org/C126894567","wikidata":"https://www.wikidata.org/wiki/Q105650","display_name":"Urology","level":1,"score":0.3941898047924042},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.384274959564209},{"id":"https://openalex.org/C141071460","wikidata":"https://www.wikidata.org/wiki/Q40821","display_name":"Surgery","level":1,"score":0.3817911446094513},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.34477323293685913},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.335289865732193},{"id":"https://openalex.org/C121332964","wikidata":"https://www.wikidata.org/wiki/Q413","display_name":"Physics","level":0,"score":0.0},{"id":"https://openalex.org/C87355193","wikidata":"https://www.wikidata.org/wiki/Q411","display_name":"Astrobiology","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000971","descriptor_name":"Antineoplastic Combined Chemotherapy Protocols","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D000971","descriptor_name":"Antineoplastic Combined Chemotherapy Protocols","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":false},{"descriptor_ui":"D000971","descriptor_name":"Antineoplastic Combined Chemotherapy Protocols","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D001855","descriptor_name":"Bone Marrow Diseases","qualifier_ui":"Q000139","qualifier_name":"chemically induced","is_major_topic":false},{"descriptor_ui":"D001855","descriptor_name":"Bone Marrow Diseases","qualifier_ui":"Q000517","qualifier_name":"prevention & control","is_major_topic":true},{"descriptor_ui":"D002330","descriptor_name":"Carmustine","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D003520","descriptor_name":"Cyclophosphamide","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D005047","descriptor_name":"Etoposide","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008223","descriptor_name":"Lymphoma","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008942","descriptor_name":"Mitoxantrone","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D008942","descriptor_name":"Mitoxantrone","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D008942","descriptor_name":"Mitoxantrone","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":false},{"descriptor_ui":"D016026","descriptor_name":"Bone Marrow Transplantation","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true}],"locations_count":3,"locations":[{"id":"doi:10.1200/jco.1994.12.1.141","doi":"https://doi.org/10.1200/jco.1994.12.1.141","is_oa":false,"landing_page_url":"https://doi.org/10.1200/jco.1994.12.1.141","pdf_url":null,"source":{"id":"https://openalex.org/S15137598","display_name":"Journal of Clinical Oncology","issn_l":"0732-183X","issn":["0732-183X","1527-7755"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Oncology","raw_type":"journal-article"},{"id":"pmid:8270970","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/8270970","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of clinical oncology : official journal of the American Society of Clinical Oncology","raw_type":"Clinical Trial"},{"id":"pmh:oai:CiteSeerX.psu:10.1.1.982.664","doi":null,"is_oa":false,"landing_page_url":"http://citeseerx.ist.psu.edu/viewdoc/summary?doi=10.1.1.982.664","pdf_url":null,"source":null,"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"http://hwmaint.jco.ascopubs.org/cgi/reprint/12/1/141.pdf","raw_type":"text"}],"best_oa_location":null,"sustainable_development_goals":[{"score":1.0,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":28,"referenced_works":["https://openalex.org/W1584323144","https://openalex.org/W1607591440","https://openalex.org/W1846648891","https://openalex.org/W1852266951","https://openalex.org/W1888835857","https://openalex.org/W1889677868","https://openalex.org/W1973461238","https://openalex.org/W2025112061","https://openalex.org/W2035149126","https://openalex.org/W2043410690","https://openalex.org/W2055307705","https://openalex.org/W2061653881","https://openalex.org/W2071060238","https://openalex.org/W2127264662","https://openalex.org/W2152309833","https://openalex.org/W2170639142","https://openalex.org/W2178078358","https://openalex.org/W2231732623","https://openalex.org/W2258178785","https://openalex.org/W2313423582","https://openalex.org/W2316881404","https://openalex.org/W2343527457","https://openalex.org/W2404046180","https://openalex.org/W2409716575","https://openalex.org/W2416197813","https://openalex.org/W2416825045","https://openalex.org/W2417789065","https://openalex.org/W2419039099"],"related_works":["https://openalex.org/W2992868376","https://openalex.org/W1846648891","https://openalex.org/W2117488134","https://openalex.org/W11525018","https://openalex.org/W2171285972","https://openalex.org/W2333126530","https://openalex.org/W1584323144","https://openalex.org/W2253178268","https://openalex.org/W2115587079"],"abstract_inverted_index":{"PURPOSE:":[0],"We":[1],"conducted":[2],"a":[3,240,257],"dose-finding":[4],"study":[5],"of":[6,39,45,57,68,118,131,141,176,196,210,227],"mitoxantrone":[7],"(MITO)":[8],"in":[9,19,261],"combination":[10],"with":[11,92,122,134,148,157,232,253],"high-dose":[12],"cyclophosphamide,":[13],"carmustine":[14],"(BCNU),":[15],"and":[16,52,178,189,212,225,248,256],"etoposide":[17],"(CBV)":[18],"refractory":[20,93],"lymphoma":[21],"undergoing":[22],"autologous":[23],"bone":[24],"marrow":[25,197],"transplantation":[26],"(ABMT).":[27],"The":[28,109],"objective":[29],"were":[30,83,97],"to":[31,71,85,113,137,160,205,245],"determine":[32],"the":[33,36,42,54,186,194,206],"following:":[34],"(1)":[35,179],"maximum-tolerated":[37,110],"dose":[38,61,111,175],"MITO,":[40,211],"(2)":[41,183],"extramedullary":[43],"toxicity":[44,202,255],"this":[46,262],"regimen,":[47],"(3)":[48,190],"its":[49],"antitumor":[50],"activity,":[51],"(4)":[53],"pharmacokinetic":[55],"characteristics":[56],"MITO":[58,69,95,177,233,243],"at":[59],"each":[60],"level.":[62],"PATIENTS":[63],"AND":[64],"METHODS:":[65],"Escalating":[66],"doses":[67,135,158],"(15":[70],"90":[72,123,149],"mg/m2,":[73],"single":[74],"bolus":[75],"infusion":[76,198],"on":[77,193],"day":[78,195],"-8)":[79],"followed":[80],"by":[81,99],"CBV":[82,249],"administered":[84,174,252],"20":[86],"patients":[87,120,146,155,230],"(mean":[88],"age,":[89],"38.5":[90],"years)":[91],"lymphoma.":[94],"concentrations":[96],"determined":[98],"high-performance":[100],"liquid":[101],"chromatography":[102],"(HPLC).":[103],"RESULTS:":[104],"No":[105],"toxic":[106],"death":[107],"occurred.":[108],"appears":[112],"be":[114,251],"75":[115,138,161,246],"mg/m2.":[116,139],"Two":[117],"five":[119],"treated":[121,133,147,156,231],"mg/m2":[124,150,162,238],"developed":[125],"severe":[126],"organ":[127],"toxicity,":[128],"versus":[129],"zero":[130],"15":[132],"up":[136,159],"Duration":[140],"neutropenia":[142],"was":[143,171,203,222],"longer":[144],"for":[145,154],"(31.7":[151],"days)":[152,164],"than":[153],"(22.1":[163],"(P":[165],"<":[166],".05).":[167],"A":[168,216],"linear":[169],"relationship":[170],"observed":[172,223],"between":[173],"plasma":[180,191,214],"peak":[181],"value,":[182],"area":[184],"under":[185],"curve":[187],"(AUC),":[188],"concentration":[192],"(day":[199],"0).":[200],"Hematologic":[201],"related":[204],"terminal":[207],"half-life":[208],"(T1/2)":[209],"day-0":[213],"concentration.":[215],"high":[217],"complete":[218],"response":[219],"(CR)":[220],"rate":[221,260],"(60%),":[224],"eight":[226],"11":[228],"(73%)":[229],">":[234],"or":[235],"=":[236],"60":[237],"achieved":[239],"CR.":[241],"CONCLUSION:":[242],"(up":[244],"mg/m2)":[247],"can":[250],"acceptable":[254],"promising":[258],"CR":[259],"poor-risk":[263],"population,":[264],"justifying":[265],"further":[266],"phase":[267],"II":[268],"studies.":[269]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W1769466758","counts_by_year":[{"year":2026,"cited_by_count":1},{"year":2020,"cited_by_count":1},{"year":2012,"cited_by_count":1}],"updated_date":"2026-11-17T12:49:18.490984","created_date":"2016-06-24T00:00:00"}
